Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities
Y Zhang, H Fang, J Feng, Y Jia, X Wang…
Index: Zhang, Yingjie; Fang, Hao; Feng, Jinhong; Jia, Yuping; Wang, Xuejian; Xu, Wenfang Journal of Medicinal Chemistry, 2011 , vol. 54, # 15 p. 5532 - 5539
Full Text: HTML
Citation Number: 32
Abstract
Histone deacetylase (HDAC) has emerged as an attractive target for the development of antitumor agents during the past decade. Previously tetrahydroisoquinoline-bearing hydroxamic acid analogue, ZYJ-25e (1), was identified and validated as a potent histone deacetylase inhibitor (HDACi) with marked in vitro and in vivo antitumor potency. In the present study, further modification of 1 led to another more potent, orally active HDACi, ...
Related Articles:
[Page; McClory; Mischki; Schmidt; Butterworth; St-Onge; Labarre; Payza; Brown Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 2 p. 167 - 170]
[Bioorganic and Medicinal Chemistry, , vol. 10, # 6 p. 1719 - 1729]
[Bioorganic and Medicinal Chemistry, , vol. 10, # 6 p. 1719 - 1729]